4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors

被引:40
作者
Ishida, J
Hattori, K
Yamamoto, H
Iwashita, A
Mihara, K
Matsuoka, N
机构
[1] Med Chem Res Labs, Yodogawa Ku, Osaka 5328514, Japan
[2] Fujisawa Pharmaceut Co Ltd, Med Biol Res Labs, Yodogawa Ku, Osaka 5328514, Japan
关键词
PARP-1; poly(ADP-ribose) polymerase; 4-phenyl-1,2,3,6-tetrahydropyridine;
D O I
10.1016/j.bmcl.2005.06.094
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have shown that a 4-phenyl-1,2,3,6-tetrahydropyridine fragment plays an important role in improving inhibitory potency against poly(ADP-ribose) polymerise-1 (PARP-1). Various benzamide analogues linked with this fragment via alkyl spacers have been prepared and evaluated. As a result, some of them have been found to be highly potent PARP-1 inhibitors. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4221 / 4225
页数:5
相关论文
共 25 条
[21]  
Szabo C., 2000, CELL DEATH ROLE PARP
[22]  
Szabo C., 2001, [No title captured], Patent No. [WO0142219A3, 0142219]
[23]   Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia [J].
Takahashi, K ;
Pieper, AA ;
Croul, SE ;
Zhang, J ;
Snyder, SH ;
Greenberg, JH .
BRAIN RESEARCH, 1999, 829 (1-2) :46-54
[24]   The therapeutic potential of poly(ADP-ribose) polymerase inhibitors [J].
Virág, L ;
Szabó, C .
PHARMACOLOGICAL REVIEWS, 2002, 54 (03) :375-429
[25]   A significantly improved condition for cyclization of phenethylcarbamates to N-alkylated 3,4-dihydroisoquinolones [J].
Wang, XJ ;
Tan, J ;
Grozinger, K .
TETRAHEDRON LETTERS, 1998, 39 (37) :6609-6612